As a research subgroup at the Princess Máxima Center for Pediatric Oncology (The Máxima, The Netherlands),
we focus on molecular characterization of primary (non-)rhabdomyosarcoma tumors
from pediatric patients.
The molecular characterization is performed via high-throughput
technologies (whole genome/exome and bulk mRNA sequencing) and also encompasses a number of pre-clinical models (tumoroids)
derived from primary tumors.